QQ客服 官方微博 反馈留言

	Evaluating the efficacy, safety and tolerability of serelaxin when added to standard therapy in asian patients with acute heart failure: The RELAX-AHF-ASIA trial
	Sato, N.; Lam, C. S.; Teerlink, J. R.; Greenberg, B. H.; Tsutsui, H.; Oh, B. H.; Zhang, J.; Hua, T. A.; Wang, X. L.; Ge, J.
	2015
卷号	17期号:,SI页码:41-41
ISSN号	1388-9842
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6662314
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Sato, N.,Lam, C. S.,Teerlink, J. R.,et al. Evaluating the efficacy, safety and tolerability of serelaxin when added to standard therapy in asian patients with acute heart failure: The RELAX-AHF-ASIA trial[J],2015,17(,SI):41-41.
APA	Sato, N..,Lam, C. S..,Teerlink, J. R..,Greenberg, B. H..,Tsutsui, H..,...&Ge, J..(2015).Evaluating the efficacy, safety and tolerability of serelaxin when added to standard therapy in asian patients with acute heart failure: The RELAX-AHF-ASIA trial.,17(,SI),41-41.
MLA	Sato, N.,et al."Evaluating the efficacy, safety and tolerability of serelaxin when added to standard therapy in asian patients with acute heart failure: The RELAX-AHF-ASIA trial".17.,SI(2015):41-41.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。